Clinical Trial Update: Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage

View source ↗

Summary

Completed clinical trial evaluating four-factor prothrombin complex concentrate for reversing DOAC-associated intracranial hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Direct Oral Anticoagulant-associated Intracranial Hemorrhage
• Intracranial Hemorrhage

Drugs mentioned

• 4-factor Prothrombin Complex Concentrate (4F-PCC) (Four-factor prothrombin complex concentrate)

Snippet

Sponsor: Methodist Health System | Conditions: Intracranial Hemorrhage | Status: COMPLETED